Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Caixia Dou"'
Autor:
Jianyu Liu, Minghai Tang, Tao Li, Zhengying Su, Zejiang Zhu, Caixia Dou, Yan Liu, Heying Pei, Jianhong Yang, Haoyu Ye, Lijuan Chen
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Externí odkaz:
https://doaj.org/article/62b2acb3e46243b9928d4c0135d3e767
Autor:
Jianyu Liu, Minghai Tang, Tao Li, Zhengying Su, Zejiang Zhu, Caixia Dou, Yan Liu, Heying Pei, Jianhong Yang, Haoyu Ye, Lijuan Chen
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Post-myocardial infarction heart failure (post-MI HF) is one of the leading global causes of death, and current prevention and treatment methods still cannot avoid the increasing incidence. Honokiol (HK) has previously been reported to improve myocar
Externí odkaz:
https://doaj.org/article/3e23cf59dba741579293435566af7014
Autor:
Zejiang Zhu, Caixia Dou, Lijuan Chen, Qiaoqiao Hu, Peng Bai, Rongsheng Tong, Zhengying Su, Lulu Cai, Bai Lan, Junfeng Yan, Wuyu Zhang, Minghai Tang
Publikováno v:
Chinese Chemical Letters. 31:915-918
β-Elemene is a volatile oil used for the treatment of cancer, but poor solubility, low bioavailability, and various adverse reactions limit its application. For ameliorating risks of the venous toxicity of β-elemene, intravenously injectable micell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e4997cdf9324bcdd697bfd10da82adf6
https://doi.org/10.1016/j.cclet.2020.01.008
https://doi.org/10.1016/j.cclet.2020.01.008
Autor:
Jianyu Liu, Minghai Tang, Tao Li, Zhengying Su, Zejiang Zhu, Caixia Dou, Yan Liu, Heying Pei, Jianhong Yang, Haoyu Ye, Lijuan Chen
Publikováno v:
Frontiers in pharmacology. 13
Post-myocardial infarction heart failure (post-MI HF) is one of the leading global causes of death, and current prevention and treatment methods still cannot avoid the increasing incidence. Honokiol (HK) has previously been reported to improve myocar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e3145e5bd8c409d30366ddc7b77aea6
https://pubmed.ncbi.nlm.nih.gov/36238543
https://pubmed.ncbi.nlm.nih.gov/36238543
Publikováno v:
Oxidative Medicine and Cellular Longevity
Oxidative Medicine and Cellular Longevity, Vol 2021 (2021)
Oxidative Medicine and Cellular Longevity, Vol 2021 (2021)
Clostridium butyricum (CB) is a naturally occurring probiotic compound that can alleviate the oxidative damage induced by enterotoxigenic Escherichia coli K88 (ETEC K88) in porcine intestinal epithelial (IPEC-J2) cells. In this study, we investigate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e49e6bc5adaf04a49fab8319a0d6d06a
http://europepmc.org/articles/PMC8321755
http://europepmc.org/articles/PMC8321755
Autor:
Wanhua Zhang, Tao Yang, Yuquan Wei, Linyu Yang, Aihua Peng, Shengyong Yang, Jun He, Minghai Tang, Haoyu Ye, Lei Lei, Ting Niu, Caixia Dou, Muzhou Li, Lijuan Chen, Mingli Xiang, Yong Chen, Jiang Liu, Xue Yuan
Publikováno v:
Journal of Medicinal Chemistry. 62:4158-4173
A series of pyrrolo[2,3- d]pyrimidine derivatives were prepared and optimized for cytotoxic activities against FLT3-ITD mutant cancer cells. Among them, compound 9u possessed nanomolar FLT3 inhibitory activities and subnanomolar inhibitory activities
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::645c4524f0d8821ef09cb9a8042d53d0
https://doi.org/10.1021/acs.jmedchem.9b00223
https://doi.org/10.1021/acs.jmedchem.9b00223